These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 27466819

  • 1. Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
    Stanojlovic M, Pang X, Lin Y, Stone S, Cvetanovic M, Lin W.
    PLoS One; 2016; 11(7):e0160158. PubMed ID: 27466819
    [Abstract] [Full Text] [Related]

  • 2. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA, Welsh ME, Carter DE, Karlik SJ.
    J Neuroimmunol; 2009 Apr 30; 209(1-2):6-15. PubMed ID: 19233483
    [Abstract] [Full Text] [Related]

  • 3. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM, Freeman KG, Larson RD, Edwards GL, White LJ.
    J Neurosci Res; 2015 May 30; 93(5):697-706. PubMed ID: 25510644
    [Abstract] [Full Text] [Related]

  • 4. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice.
    Bannerman PG, Hahn A, Ramirez S, Morley M, Bönnemann C, Yu S, Zhang GX, Rostami A, Pleasure D.
    Brain; 2005 Aug 30; 128(Pt 8):1877-86. PubMed ID: 15901645
    [Abstract] [Full Text] [Related]

  • 5. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
    Yue Y, Stanojlovic M, Lin Y, Karsenty G, Lin W.
    J Neuroinflammation; 2019 Feb 01; 16(1):23. PubMed ID: 30709400
    [Abstract] [Full Text] [Related]

  • 6. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Feb 01; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 7. Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.
    Seabrook TJ, Littlewood-Evans A, Brinkmann V, Pöllinger B, Schnell C, Hiestand PC.
    J Neuroinflammation; 2010 Dec 22; 7():95. PubMed ID: 21176212
    [Abstract] [Full Text] [Related]

  • 8. PI3Kγ inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice.
    Li H, Park D, Abdul-Muneer PM, Xu B, Wang H, Xing B, Wu D, Li S.
    Neuroscience; 2013 Dec 03; 253():89-99. PubMed ID: 24012746
    [Abstract] [Full Text] [Related]

  • 9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 03; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 10. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG, Hahn A.
    J Neurol Sci; 2007 Sep 15; 260(1-2):23-32. PubMed ID: 17493638
    [Abstract] [Full Text] [Related]

  • 11. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
    Mills Ko E, Ma JH, Guo F, Miers L, Lee E, Bannerman P, Burns T, Ko D, Sohn J, Soulika AM, Pleasure D.
    J Neuroinflammation; 2014 Jun 12; 11():105. PubMed ID: 24924222
    [Abstract] [Full Text] [Related]

  • 12. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M, Shu Y, Yang Y, Zheng X, Li R, Wang Y, Dai Y, Qiu W, Lu Z, Hu X.
    Neurochem Int; 2014 Jan 12; 64():64-72. PubMed ID: 24274996
    [Abstract] [Full Text] [Related]

  • 13. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH, Jeon SJ, Cho KS, Moon E, Sapkota A, Jun HS, Ryu JH, Choi JW.
    Mol Neurobiol; 2018 Apr 12; 55(4):3007-3020. PubMed ID: 28456941
    [Abstract] [Full Text] [Related]

  • 14. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia.
    Shiote M, Nagano I, Ilieva H, Murakami T, Narai H, Ohta Y, Nagata T, Shoji M, Abe K.
    Neuroscience; 2005 Apr 12; 132(1):175-82. PubMed ID: 15780476
    [Abstract] [Full Text] [Related]

  • 15. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y, Nomura T, Bochimoto H, Murakami K, Tanaka T, Watanabe T, Yoshida S.
    Neurochem Int; 2015 Feb 12; 81():16-27. PubMed ID: 25595039
    [Abstract] [Full Text] [Related]

  • 16. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J, Paul F, Aktas O, Müller-Wielsch K, Dörr J, Dörr S, Bharathi BS, Glumm R, Schmitz C, Steinbusch H, Raine CS, Tsokos M, Nitsch R, Zipp F.
    Ann Neurol; 2009 Sep 12; 66(3):310-22. PubMed ID: 19798635
    [Abstract] [Full Text] [Related]

  • 17. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 12; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.
    Choi EY, Lim JH, Neuwirth A, Economopoulou M, Chatzigeorgiou A, Chung KJ, Bittner S, Lee SH, Langer H, Samus M, Kim H, Cho GS, Ziemssen T, Bdeir K, Chavakis E, Koh JY, Boon L, Hosur K, Bornstein SR, Meuth SG, Hajishengallis G, Chavakis T.
    Mol Psychiatry; 2015 Jul 12; 20(7):880-888. PubMed ID: 25385367
    [Abstract] [Full Text] [Related]

  • 20. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD.
    J Neuropathol Exp Neurol; 2002 Jan 12; 61(1):23-32. PubMed ID: 11829341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.